Correction

Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs

N Engl J Med 1999; 341:548August 12, 1999

Article

Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs (Review Article, N Engl J Med 1999:340;1888 - 1899) . On page 1896, in Table 2, the recommendation for “Active gastroduodenal ulcer NSAID discontinued” should have read, “Treatment with an H₂-receptor antagonist (e.g., 800 mg of cimetidine, 300 mg of ranitidine or nizatidine, or 40 mg of famotidine daily before bedtime),” not “150 mg of ranitidine or nizatidine,” as printed.

Citing Articles (3)

Citing Articles

1. 1

   Larry H. Lai, Joseph J.Y. Sung. (2007) Helicobacter pylori and benign upper digestive disease. Best Practice & Research Clinical Gastroenterology 21:2, 261-279
   CrossRef

2. 2

   Lyndal R. HARBORNE, Claire E. ALEXANDER, Andrew J. THOMSON, Denis St J. O'REILLY, Ian A. GREER. (2005) Outcomes of pregnancy complicated by thyroid disease. The Australian and New Zealand Journal of Obstetrics and Gynaecology 45:3, 239-242
   CrossRef

3. 3

   Tzeng-Ji Chen, Li-Fang Chou, Shinn-Jang Hwang. (2003) Application of a data-mining technique to analyze coprescription patterns for antacids in Taiwan. Clinical Therapeutics 25:9, 2453-2463
   CrossRef